James Robert Arnold Jr. insider trades: Nextgen Healthcare (NXGN) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where James reports to the SEC
Open-market buys and sales
7 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 30, 2021 | NXGN | ↑ Buy | 5,000 | $15.47 | $77K | Direct | Nov 30, 2021 (0d) |
| Mar 13, 2020 | NXGN | ↑ Buy | 5,000 | $9.20 | $46K | Direct | Mar 13, 2020 (0d) |
| Mar 15, 2018 | QSII | ↑ Buy | 40,000 | $13.10 | $524K | Direct | Mar 15, 2018 (0d) |
| Jun 14, 2016 | QSII | ↑ Buy | 8,300 | $12.02 | $100K | Direct | Jun 14, 2016 (0d) |
| May 30, 2008 | NUAN | ↓ Sell | 136,000 | $19.81 | $2.7M | Direct | Jun 3, 2008 (4d) |
| Feb 24, 2006 | NUAN | ↓ Sell | 50,000 | $10.75 | $538K | Direct | Feb 27, 2006 (3d) |
| Feb 21, 2006 | NUAN | ↓ Sell | 25,000 | $10.15 | $254K | Direct | Feb 22, 2006 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About James Robert Arnold Jr.'s insider trades
James Robert Arnold Jr. is Chief Financial Officer at Nextgen Healthcare (NXGN). Since Feb 21, 2006, James has reported 4 open-market purchases worth $747K and 3 sales worth $3.5M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (21 filings), shares withheld for taxes (13 filings), option exercises (6 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NXGN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.